Paper published in a journal (Scientific congresses and symposiums)
Drug resistance among therapy-naive HIV-infected patients studied by sequencing and VERSANT (TM) HIV-1 resistance assays (LiPA) has limited impact on treatment response
Derdelinckx, I.; Van Laethem, K.; Maes, B. et al.
2002In Antiviral Therapy, 7 (Suppl. 1), p. 181
Peer Reviewed verified by ORBi
 

Files


Full Text
Derdelinckx Drug resistance 2002.pdf
Publisher postprint (135.63 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Pharmacy, pharmacology & toxicology
Immunology & infectious disease
Author, co-author :
Derdelinckx, I.
Van Laethem, K.
Maes, B.
Schrooten, Y.
Dewit, S.
Florence, Eric
Fransen, K.
Ribas, S. G.
Marissens, D.
Moutschen, Michel  ;  Université de Liège - ULiège > Département des sciences cliniques > Immunopathologie - Transplantation
Van Wijngaerden, E.
Vaira, Dolorès ;  Centre Hospitalier Universitaire de Liège - CHU > Immuno-hématologie
Zissis, G.
Van Ranst, M.
Vandamme, Anne-Mieke
More authors (5 more) Less
Language :
English
Title :
Drug resistance among therapy-naive HIV-infected patients studied by sequencing and VERSANT (TM) HIV-1 resistance assays (LiPA) has limited impact on treatment response
Publication date :
2002
Journal title :
Antiviral Therapy
ISSN :
1359-6535
eISSN :
2040-2058
Publisher :
Int Medical Press Ltd, London, United Kingdom
Volume :
7
Issue :
Suppl. 1
Pages :
S181
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 31 May 2010

Statistics


Number of views
30 (3 by ULiège)
Number of downloads
23 (3 by ULiège)

Bibliography


Similar publications



Contact ORBi